CHEBI:24396 - glycopeptide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name glycopeptide
ChEBI ID CHEBI:24396
Definition Any carbohydrate derivative that consists of glycan moieties covalently attached to the side chains of the amino acid residues that constitute the peptide.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:24395, CHEBI:5478
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing glycopeptide (CHEBI:24396) is a carbohydrate derivative (CHEBI:63299)
glycopeptide (CHEBI:24396) is a peptide (CHEBI:16670)
Incoming (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid (CHEBI:141615) is a glycopeptide (CHEBI:24396)
6-O-butyryl-N-acetylmuramyl-L-alanyl-D-isoglutamine N-hydroxy-5-norbornene-2,3-dicarboxylmidyl ester (CHEBI:63777) is a glycopeptide (CHEBI:24396)
N-acetyl-β-D-glycosaminyl glycopeptide (CHEBI:17149) is a glycopeptide (CHEBI:24396)
N-{β-D-Man-(1→2)-β-D-Man-(1→2)-β-D-ManO[CH2]3S[CH2]2NHC(O)[CH2O]4C(O)[CH2]2S[CH2]2C(O)}-YGKDVKDLFDYAQE-NH-[CH2O]3[CH2]2C(O)NHC(CO2H)[CH2]4N3 (CHEBI:141770) is a glycopeptide (CHEBI:24396)
Ara6-ANSSFAP (CHEBI:139516) is a glycopeptide (CHEBI:24396)
Ara6-DAHATLR (CHEBI:139524) is a glycopeptide (CHEBI:24396)
Ara6-TTYVVNP (CHEBI:139525) is a glycopeptide (CHEBI:24396)
bleomycin (CHEBI:22907) is a glycopeptide (CHEBI:24396)
chloroeremomycin (CHEBI:29556) is a glycopeptide (CHEBI:24396)
chloroorienticin B (CHEBI:76058) is a glycopeptide (CHEBI:24396)
CII259-273 (CHEBI:62385) is a glycopeptide (CHEBI:24396)
dalbavancin (CHEBI:82721) is a glycopeptide (CHEBI:24396)
devancoaminyl vancomycin (CHEBI:47395) is a glycopeptide (CHEBI:24396)
epivancomycin (CHEBI:85901) is a glycopeptide (CHEBI:24396)
Gly-Aic-Ala-Gly-Cha-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62404) is a glycopeptide (CHEBI:24396)
Gly-Aic-Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62405) is a glycopeptide (CHEBI:24396)
Gly-Ala(thiazol-4-yl)-Ala-Gly-Ala(4-Py)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62400) is a glycopeptide (CHEBI:24396)
Gly-Ala(thiazol-4-yl)-Ala-Gly-Phe(3-Me)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62399) is a glycopeptide (CHEBI:24396)
Gly-Ala(thiazol-4-yl)-Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62398) is a glycopeptide (CHEBI:24396)
Gly-Chg-Ala-Gly-Ala(4-Py)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62397) is a glycopeptide (CHEBI:24396)
Gly-Chg-Ala-Gly-Phe(3-Me)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62395) is a glycopeptide (CHEBI:24396)
Gly-Chg-Ala-Gly-Tyr-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62396) is a glycopeptide (CHEBI:24396)
Gly-Cpa-Ala-Gly-Ala(4-Py)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62394) is a glycopeptide (CHEBI:24396)
Gly-Cpa-Ala-Gly-Cha-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62393) is a glycopeptide (CHEBI:24396)
Gly-Cpa-Ala-Gly-Phe(3-Me)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62392) is a glycopeptide (CHEBI:24396)
Gly-Gln-Ala-Gly-Ala(thiazol-4-yl)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62401) is a glycopeptide (CHEBI:24396)
Gly-Gln-Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62402) is a glycopeptide (CHEBI:24396)
Gly-Gln-Ala-Gly-Tyr-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62403) is a glycopeptide (CHEBI:24396)
Gly-Hle-Ala-Gly-Ala(thiazol-4-yl)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62391) is a glycopeptide (CHEBI:24396)
Gly-Hle-Ala-Gly-Cha-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62390) is a glycopeptide (CHEBI:24396)
Gly-Hle-Ala-Gly-Phe(4-F)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62389) is a glycopeptide (CHEBI:24396)
Gly-Ile-Ala-Gly-Ala(thiazol-4-yl)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62388) is a glycopeptide (CHEBI:24396)
Gly-Ile-Ala-Gly-Phe(4-F)-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62386) is a glycopeptide (CHEBI:24396)
Gly-Ile-Ala-Gly-Tyr-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:62387) is a glycopeptide (CHEBI:24396)
glycopeptidolipid (CHEBI:59375) is a glycopeptide (CHEBI:24396)
IleΨ(CH2CH2)Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:63128) is a glycopeptide (CHEBI:24396)
IleΨ[(E)-CH=CH]Ala-Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:63126) is a glycopeptide (CHEBI:24396)
Ile-AlaΨ(CH2CH2)Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:63130) is a glycopeptide (CHEBI:24396)
Ile-AlaΨ[(E)-CH=CH]Gly-Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:63129) is a glycopeptide (CHEBI:24396)
Ile-Ala-GlyΨ(CH2CH2)Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:63133) is a glycopeptide (CHEBI:24396)
Ile-Ala-GlyΨ[(E)-CH=CH]Phe-Lys(5-GalO)-Gly-Glu-Gln-Gly-Pro-Lys-Gly-Glu-Thr (CHEBI:63132) is a glycopeptide (CHEBI:24396)
muramyl dipeptide (CHEBI:59414) is a glycopeptide (CHEBI:24396)
oritavancin (CHEBI:82699) is a glycopeptide (CHEBI:24396)
peplomycin (CHEBI:135909) is a glycopeptide (CHEBI:24396)
phleomycin D1 (CHEBI:75046) is a glycopeptide (CHEBI:24396)
ristocetin (CHEBI:85129) is a glycopeptide (CHEBI:24396)
tallysomycin S10B (CHEBI:67810) is a glycopeptide (CHEBI:24396)
teicoplanin A2 (CHEBI:34994) is a glycopeptide (CHEBI:24396)
teicoplanin A3-1 (CHEBI:34999) is a glycopeptide (CHEBI:24396)
telavancin (CHEBI:71229) is a glycopeptide (CHEBI:24396)
theopalauamide (CHEBI:52550) is a glycopeptide (CHEBI:24396)
undecaprenyldiphospho-N-acetylmuramoyl peptide (CHEBI:27194) is a glycopeptide (CHEBI:24396)
vancomycin (CHEBI:28001) is a glycopeptide (CHEBI:24396)
zorbamycin (CHEBI:67811) is a glycopeptide (CHEBI:24396)
IUPAC Name
glycopeptides
Last Modified
23 August 2018